Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment

Nephrology Dialysis Transplantation

Volumn 16, Issue 2, 2001, Pages 335-340

  Nguyen Khoa, Thao ^a,b   Massy, Ziad A ^b,c   Pascal De Bandt, Jean ^a   Kebede, Messeret ^a   Salama, Lucie ^a   Lambrey, Guy ^c   Witko Sarsat, Véronique ^b   Drüeke, Tilman B ^b   Lacour, Bernard ^a   Thévenin, Marc ^a  

^a Biochemistry A   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Beauvais Hospital   (France)

Author keywords

Advanced oxidation protein products (AOPP); Glutathione; Haemodialysis; Highly sensitive C reactive protein assay; Inflammation; Oxidative stress; Vitamins

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ASCORBIC ACID; BICARBONATE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CELLULOSE; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; EDETIC ACID; FERRITIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; IRON; MALTOFER; OXIDIZED LOW DENSITY LIPOPROTEIN; PYROGALLOL; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN; TRIACYLGLYCEROL; UBIDECARENONE; UREA; VITAMIN; WATER;

ADULT; AGE; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON OVERLOAD; LIPID BLOOD LEVEL; MALE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SMOKING; TREATMENT OUTCOME;

EID: 0035143746     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.2.335     Document Type: Article

References (26)

1. Comparative mortality from cardiovascular disease in patients with chronic renal failure
2. Atherosclerosis and arteriosclerosis in chronic renal failure
3. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
4. Hemodialysis membrane induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood
5. Lipid peroxidation abnormalities in hemodialyzed patients
6. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
7. Selenium status, fatty acids, vitamins A and E, and aging: The Nove study
8. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure
9. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
10. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure
11. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron
12. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients
13. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
14. Protection against oxidants
15. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
16. Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis
17. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase
18. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
19. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
20. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: A randomized prospective study
21. Serum coenzyme Q10 in uremic patients on chronic hemodialysis
22. Susceptibility of VLDL to oxidation in patients on regular haemodialysis
23. Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation
24. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
25. Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin
26. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia